期刊文献+

脂联素与1型糖尿病肾病及可溶性血管细胞黏附分子-1的关系 被引量:11

Relation between serum levels of adiponectin and soluble vascular cell adhesion molecule and diabetic nephropathy in type 1 diabetes mellitus
下载PDF
导出
摘要 目的:探讨1型糖尿病患者血清脂联素与肾小球滤过率之间的关系。方法:用酶联免疫法对75例1型糖尿病患者和40例对照组血清脂联素和可溶性血管细胞黏附分子-1水平进行测定。结果:1型糖尿病患者血清脂联素水平明显高于对照组[(17.47±6.36)μg/mL vs(13.98±5.63)μg/mL,P<0.01)],且脂联素与肾小球滤过率呈负相关,与可溶性血管细胞黏附分子-1呈正相关。结论:1型糖尿病患者血清脂联素与患者的肾功能减退密切相关,并与内皮和血管损伤有关。 Objective To analyze the relationship between serum levels of adiponectin and soluble vascular cell adhesion molecule and renal function in type 1 diabetes mellitus. Methods Clinical history of 75 cases of type 1 diabetes mellitus were reviewed. Results (1) Significant differences in serum levels of adiponectin were observed between the patients (17.47 ± 6.36) μg/mL and control subjects (13.98±5. 63)μg/mL, (P〈0.01). (2) There were inverse correlations between adiponectin and BMI, insulin, WHR, fasting TG and glomerular filtration rate, and positive correlations between adiponectin and sVCAM-1 HDL, LDL, and total cholesterol. Conclusion Increased adiponectin level is observed in type 1 diabetic patients and is positively associated with impairment of renal function, and there is a positive association between adiponectin and endothelial damage.
出处 《实用诊断与治疗杂志》 2008年第4期244-245,248,共3页 Journal of Practical Diagnosis and Therapy
关键词 1型糖尿病 脂联素 可溶性血管细胞黏附分子-1 糖尿病肾病 Type 1 diabetes mellitus adiponectin sVCAM-1 diabetic nephropathy
  • 相关文献

参考文献11

  • 1Kumada M,Kihara S,Sumil,s uji S,et a1. Association Of hypo aIJiponectinemia with coronary artery disease in men[J].Arterioscler Thromb Vasc.Biol,2003,23(1):85-89.
  • 2Hadjadi S, Aubert R, Fumeron F, et al. Increased plasma adiponectin concentrations are associated with microanglopathy in type 1 diabetic subjects[J]. Diabetologia, 2005, 48(6) : 1088- 1092.
  • 3Mallamaci F, Zoccali C, Cuzzola F, et al. Adiponectin in essential hypertension[J]. J Nephrol, 2002, 15(5):507-511.
  • 4Goldstein B J, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function[J]. J Clin Endocrinol Metab, 2004, 89(6):2563-2568.
  • 5Fasshauer M, Klein J, Neumann S, et al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes[J]. Biochem Biophys Res Commun, 2002, 290(3):1084-1089.
  • 6Arita Y, Kihara S, Ouchl N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity[J]. Biochem Biophys Res Commun, 1999, 257(1) :79-83.
  • 7Tan K C, Xu A, Chow W S, et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation[J].J Clin Endocrinol Metab, 2004, 89(2):765-769.
  • 8Hadjadj S, Aubert R, Fumeron F, et al. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects[J]. Diabetologia, 2005, 48(6):1088-1092.
  • 9Becker B, Kronenberg F, Kielstein J T, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study[J]. J AmSoc Nephrol, 2005, 16(4) :1091-1098.
  • 10Chudek J, Adamczak M, Karkoszka H, et at. Plasma adiponectin concentration before and after successful kidney transplantation[J]. Transplant Proc, 2003, 35(6):2186-2189.

二级参考文献12

  • 1叶江枫,戚好文,梁军,蒙育林,任东青.维甲酸及氟伐他汀对放射性肺损伤的治疗作用[J].第四军医大学学报,2003,24(18):1707-1709. 被引量:7
  • 2Yang Y, Zhang S Y, Sich M, et al. Glomerlar extracellular martrix and growth factors in diffuse mesangial aclerosis[J].Pediatr Nephrol, 2001,16 ( 5 ) : 409.
  • 3Navarro J F, Mora C, Macia M,et al. Inflammatory parameters are independently associated with urinary albumin in Type 2 diabetes mellitus[J]. Am J Kidney Dis,2003,42(1):53.
  • 4Chen S, Hong S W, Iglesias-de la Cruz M C, et al. The key role of the transforming growth factor beta system in the pathogenesis of diabetic nephropathy[J]. Ren Fail, 2001,23:471.
  • 5Teicher B A. The transforming growth factor beta Proteins:discoveries and insights [J].Cancer Metasis Rev, 2001,20 ( 1 ) :133.
  • 6Kaneto H, Morrissey J, Klahr S. Increased expression of TGF betal mRNA in thc obstructed kidney of rats with unilateral ureteral ligation[J]. Kidney Int,1993,44(2) :313.
  • 7Chen S, Hong S W, Lglesias de la Cruz M C, et al. The key role of the transforming growth factor-beta system in the pathogensis of diabetic nephrothy[J]. Ren Fail ,2001,23(4) :471.
  • 8Leehey D J, Singh A K, Alavi N, et al. Role of angiotension Ⅱ in diabetic nephropathy[J]. Kidney Int, 2000,58(Suppl 77):s93.
  • 9Singh R, Song R H, Alavi N, et al. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-betal[J]. Exp Nephrol, 2001,9(4):249.
  • 10Massy Z A, Kim Y, Guijarro C, et al. Low-density lipoprotein induced expression of interleukin-6, a maker of human mesangial cell inflammation: Effects if oxidation and modulation by lovastin[J]. Biochem Biophys Res Commun, 2000,267 (2) :536.

共引文献16

同被引文献86

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部